NCT02444390 - Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

May 19, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

July 1, 2022

Conditions

Metastatic Breast Cancer

Interventions

PROCEDURE

Biopsy

biopsy of a metastasis

Trial Locations (12)

Institut de Cancérologie de l'Ouest/Paul Papin, Angers

Centre Jean Perrin, Clermont-Ferrand

Centre Léon Bérard, Lyon

Institut de Cancérologie de l'Ouest/Rene Gauducheau, Nantes

Centre Antoine Lacassagne, Nice

Institut Curie, Paris

Clinique Armoricaine de Radiologie, Saint-Brieuc

INSTITUT DE CANCEROLOGIE Lucien Neuwirth, Saint-Priest-en-Jarez

Centre Paul Strauss, Strasbourg

Institut Claudius Regaud, Toulouse

Institut de Cancerologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy

Gustave Roussy, Villejuif